Zota Health Care
Zota Health Care Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Zota Health Care Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Valuation
Profitability
Growth
Financial Health
Zota Health Care Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Zota Health Care Ltd, switchable between annual and quarterly views, consolidated or standalone.
Zota Health Care Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹4,225.52 Cr and reported EPS of ₹-22.50.
| Period | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 95 | 107 | 131 | 140 | 180 | 293 | 539 |
| Other Income | 2 | 1 | 2 | 2 | 1 | 2 | 7 |
| Total Income | 97 | 108 | 133 | 142 | 182 | 295 | 546 |
| Cost of Goods Sold (COGS) | 66 | 73 | 87 | 83 | 97 | 137 | 214 |
| Gross Profit | 29 | 34 | 45 | 57 | 84 | 156 | 325 |
| +Operating Expenses | 24 | 33 | 30 | 49 | 76 | 161 | 306 |
| EBITDA | 5 | 1 | 15 | 7 | 8 | -6 | 19 |
| +Non-Operating Expenses | 2 | 4 | 4 | 15 | 25 | 54 | 94 |
| Profit Before Tax (PBT) | 4 | -0 | 12 | -5 | -16 | -58 | -80 |
| +Tax Expense | 1 | -0 | 4 | 1 | -2 | -1 | -6 |
| Profit After Tax (PAT) | 3 | -0 | 9 | -6 | -14 | -57 | -74 |
| Earnings Per Share (EPS) | 1.12 | -0.09 | 3.54 | -2.29 | -5.55 | -19.70 | -21.35 |
| Diluted Shares Outstanding (Nos.) | 2 | 2 | 3 | 3 | 3 | 3 | 3 |
| +Additional Disclosures | 159 | 183 | 207 | 231 | 295 | 490 | 835 |
| Sales Growth % | — | 12.28 | 22.85 | 6.68 | 28.96 | 62.32 | 83.86 |
| YoY Sales Growth % | — | 12.28 | 22.85 | 6.68 | 28.96 | 62.32 | 83.86 |
| Material Cost % | 14 | 19 | 15 | 12 | 7 | 6 | 3 |
| Employee Cost % | 11 | 9 | 8 | 9 | 17 | 29 | 33 |
| Other Cost % | 15 | 22 | 15 | 26 | 25 | 26 | 24 |
| OPM % | 5 | 1 | 11 | 5 | 4 | -2 | 3 |
| Tax % | 29 | 43 | 28 | -23 | 11 | 2 | 7 |
| Profit Growth % | — | -107.62 | 4,364.05 | -164.81 | -148.54 | -295.45 | -30.56 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Additional Fields | 2 | -3 | 11 | -5 | -13 | -49 | -64 |
Zota Health Care segment analysis: revenue and profit mix.
Disclosed business segments at Zota Health Care with their share of revenue and profit, switchable between consolidated and standalone reporting.
Zota Health Care discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Zota Health Care Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Zota Health Care Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Zota Health Care Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Robust 91.70% quarterly sales growth indicates strong top-line expansion.
Consistent revenue growth. 30.71% (3Y CAGR) and 25.23% (5Y CAGR).
Strong 57.4% promoter holding signals high insider confidence and commitment.
Diversified product portfolio (generics, OTC, Ayurveda, nutraceuticals) taps various segments.
DAVAINDIA retail chain offers direct-to-consumer channel, enhancing brand visibility.
What can break it.
Consistent negative net profits (-61.8 Cr) raise significant sustainability concerns.
Deeply negative ROE (-36.00%) and ROCE (-17.00%) indicate inefficient capital utilization.
Negative operating profit margin (-12.15%) indicates core business unprofitability.
Quarterly profit declined -31.80% despite sales growth, impacting net income.
Negative EPS (-23.98) reflects a fundamental lack of earnings power.
What would change my mind.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 39.35. Balance sheet risk re-prices growth multiples fast.
Income thesis breaks if the dividend is cut or yield falls below 0.04%.
Zota Health Care Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Zota Health Care Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Zota Health Care Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Zota Health Care Ltd — derived from the live tape, not yesterday's close.
Zota Health Care Ltd last traded at ₹1,225.2 with an intraday range of ₹1,200–₹1,237 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹1225.20| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1315.47 | +90.27 | +7.37% |
| R3 | 1278.47 | +53.27 | +4.35% |
| R2 | 1257.73 | +32.53 | +2.66% |
| R1 | 1241.47 | +16.27 | +1.33% |
| PIVOT | 1220.73 | -4.47 | -0.36% |
| CURRENT | 1225.20 | — | — |
| S1 | 1130.47 | -94.73 | -7.73% |
| S2 | 1167.47 | -57.73 | -4.71% |
| S3 | 1183.73 | -41.47 | -3.38% |
| S4 | 1204.47 | -20.73 | -1.69% |
ZOTA is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: 1215 ~ 1224.6
Trading Inside opening range
Zota Health Care Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Zota Health Care Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Zota Health Care Ltd stood at 62.8% of traded volume, against a 20-day average of 59.4%.
Zota Health Care announcements: results, concalls, ratings, M&A.
Filings Zota Health Care sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Zota Health Care files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 173 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Zota Health Care Limited has informed the Exchange about Intimation of Schedule of Analyst/ Institutional Investor Meeting.
Disclosure under SEBI Takeover Regulations
HIMANSHU Muktilal ZOTA has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31 (5) of the Securities and Exchange Board of…
Copy of Newspaper Publication
Zota Health Care Limited has informed the Exchange about Copy of Newspaper Publication in respect of Audited Financial Results for the quarter and…
Monitoring Agency Report
Monitoring Agency Report issued by CRISIL Ratings Limited for monitoring the utilization of funds raised through Qualified Institutional Placement as…
Monitoring Agency Report
Monitoring Agency Report issued by the CRISIL Ratings Limited for monitoring the utilization of funds raised through Preferential Issue as approved…
Investor decks & rating reports.
Zota Health Care insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Zota Health Care as reported to SEBI — buying and selling signals from the people who know the business best.
Zota Health Care insider activity below tracks 5 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| KENVI ZOTA | Insider | 17 Mar 2025 | buy | +95.0 K | ₹7.36 Cr | ₹774.45 |
| HIMANSHU MUKTILAL ZOTA | Insider | 17 Mar 2025 | sell | −97.2 K | ₹7.53 Cr | ₹774.67 |
| VINODCHANDRA DHIRAJLAL MEHTA | Insider | 20 Dec 2024 | sell | −2.0 K | ₹15.61 L | ₹780.61 |
| NIRUBEN VINODKUMAR MEHTA | Insider | 02 Dec 2024 | sell | −6.1 K | ₹36.95 L | ₹608.50 |
| VINODCHANDRA DHIRAJLAL MEHTA | Insider | 02 Dec 2024 | buy | +6.1 K | ₹36.95 L | ₹608.50 |
Zota Health Care dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Zota Health Care has declared, sequenced by announce and record date.
Zota Health Care corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Zota Health Care Ltd: business, sector, key facts.
What Zota Health Care Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Zota Health Care Ltd operates in the Healthcare, listed as NSE: ZOTA.
Zota Health Care Limited is a pharmaceutical company headquartered in Surat, India, established in 1995. Its core business revolves around the development, manufacturing, and marketing of a diverse range of pharmaceutical products both domestically within India and internationally.
The company's product portfolio is extensive and caters to a broad spectrum of healthcare needs. This includes a significant presence in the generic drug market, offering affordable alternatives to branded medications. Beyond generics, Zota also manufactures and markets wellness products, over-the-counter (OTC) medications readily available without a prescription, and products rooted in traditional Ayurvedic medicine and the increasingly popular nutraceutical sector. This diversified approach allows them to tap into various segments of the healthcare market.
A key focus for Zota is addressing chronic illnesses prevalent globally. Their product line specifically includes medications designed to manage and treat conditions such as diabetes, heart disease, and thyroid disorders. This concentration on chronic care highlights a commitment to providing essential therapies for long-term health management.
In addition to its wholesale and export operations, Zota also has a retail presence in India. Operating under the brand name DAVAINDIA, these retail stores provide a direct-to-consumer channel for the company's products, enhancing brand visibility and facilitating direct customer engagement.
In summary, Zota Health Care Limited is a multifaceted pharmaceutical company with a substantial presence in India and international markets. Its strategic diversification across various product categories, including generics, wellness, OTC, Ayurvedic, and nutraceutical products, coupled with its retail and export operations, positions it for continued growth and success in the dynamic healthcare industry.
Questions investors ask about Zota Health Care Ltd (ZOTA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Zota Health Care Ltd (ZOTA)?
The current share price of Zota Health Care Ltd (ZOTA) is ₹1,225.2. Today, the stock has gained by ₹28.60 (2.39%), trading in a range of ₹1,200 to ₹1,237. The stock opened at ₹1,215 with a trading volume of 62,313 shares.
02Is Zota Health Care Ltd stock a good investment for long-term?
Zota Health Care Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹4,225.52 crores, P/E ratio of 0.00, ROE of -16.05%, and ROCE of -17.00%. The dividend yield stands at 0.08%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Zota Health Care Ltd stock?
The 52-week high price of Zota Health Care Ltd (ZOTA) is ₹0, while the 52-week low is ₹0. Currently trading at ₹1,225.2, the stock is Infinity% away from its 52-week low and -Infinity% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Zota Health Care Ltd stock at the current price?
Whether to buy Zota Health Care Ltd stock at ₹1,225.2 depends on multiple factors. The stock is currently trading with a P/E ratio of 0.00 and P/B ratio of 11.89. Today's performance shows a gain of 2.39%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Zota Health Care Ltd and when is the next dividend?
Zota Health Care Ltd offers a dividend yield of 0.08%, which means for every ₹100 invested at the current price of ₹1,225.2, you can expect to receive approximately ₹0.08 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Zota Health Care Ltd?
Zota Health Care Ltd's key financial metrics include: P/E Ratio: 0.00, P/B Ratio: 11.89, ROE: -16.05%, ROCE: -17.00%, Dividend Yield: 0.08%, EPS: ₹-22.50, Book Value: ₹103.04, and Debt-to-Equity: 38.85. The company's market cap stands at ₹4,225.52 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Zota Health Care Ltd stock performing today in the market?
Zota Health Care Ltd stock opened at ₹1,215 and is currently trading at ₹1,225.2, showing a gain of ₹28.60 (2.39%). The intraday high is ₹1,237 and low is ₹1,200. The trading volume stands at 62,313 shares, indicating moderate market participation today.
08What is the P/E ratio of Zota Health Care Ltd and what does it indicate?
Zota Health Care Ltd has a Price-to-Earnings (P/E) ratio of 0.00, which means investors are willing to pay ₹0.00 for every ₹1 of earnings. With an EPS of ₹-22.50, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Zota Health Care Ltd (ZOTA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- AHCL (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy